Cleared Traditional

K190672 - StealthStation Synergy Cranial S7 Software v.2.2.8, StealthStation Cranial Software v3.1.1

K190672 is an FDA 510(k) clearance for StealthStation Synergy Cranial S7 Softw..., manufactured by Medtronic Navigation, Inc.. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 138-day FDA review.

K190672 · Medtronic Navigation, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2019
Decision
138d
Days
Class 2
Risk

K190672 is an FDA 510(k) clearance for the StealthStation Synergy Cranial S7 Software v.2.2.8, StealthStation Cranial So.... Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Medtronic Navigation, Inc. (Louisville, US). The FDA issued a Cleared decision on July 31, 2019 after a review of 138 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtronic Navigation, Inc. devices

FDA 510(k) Submission Details - K190672

510(k) Number K190672 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 2019
Decision Date July 31, 2019
Days to Decision 138 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 148d · This submission: 138d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 331
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K190672.
Microscope Navigation
K190250 · Brainlab AG · Sep 2019
7D Surgical System
K183276 · 7D Surgical, Inc. · Aug 2019
Leksell Vantage Stereotactic System
K190887 · Elekta Instrument AB · Aug 2019
Modus Nav
K183325 · Synaptive Medical, Inc. · Jul 2019
Voyager Trajectory Array Guide (V-TAG)
K191400 · Mri Interventions, Inc. · Jun 2019
ROSA ONE Brain Application
K182417 · Medtech S.A · Feb 2019